HomeNewsBusinessRolling stock cos say deadline extension of Vande Bharat trains to help industry consolidate and plan investments

Rolling stock cos say deadline extension of Vande Bharat trains to help industry consolidate and plan investments

Industry participants said that no domestic company has the capability to individually bid for and execute the Rs 26,000-crore order within the stated timeline for delivery of 82 months.

July 20, 2022 / 19:25 IST
Story continues below Advertisement
Vande Bharat express
Vande Bharat express

The Indian Railways’ decision to extend the deadline for a tender that it released for 200 third-generation Vande Bharat trainsets is expected to help the industry form joint ventures and consortiums to increase competitive bidding for the order. Earlier this month, the Indian Railways extended the deadline for bid submission for key systems to October 10 from July 26.

Industry participants said that no domestic company has the capability to individually bid for and execute the Rs 26,000-crore order within the stated timeline for delivery of 82 months. Therefore, in order to execute the project on time, multiple players are expected to bid for the tender in a consortium or by forming joint ventures.

Story continues below Advertisement

“Not only are companies expected to design and build the Vande Bharat trains but they are also expected to carry out upgrades at Marathwada Rail Coach Factory in Latur or the Integral Coach Factory (ICF) in Chennai, which will require an investment of close to Rs 1,000 crore,” a senior executive from a domestic rolling stock manufacturer said.

Another rolling stock manufacturer said that in the last few years many wagon builders have branched out, or plan to branch out, into coach-building and are eyeing a part of the Vande Bharat train project.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show